Maxion Therapeutics

Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.

Edits on 20 Feb, 2023

edited on 20 Feb, 2023

Edits made to:

Timeline (+1 events) (+59 characters)

Timeline

February 19, 2023

Maxion Therapeutics raises $16 million in Series A funding.

edited on 20 Feb, 2023

Edits made to:

Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.

"Created via: Web app"

created this topic on 20 Feb, 2023

Edits made to:

Infobox (+2 properties)

Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.

Infobox

Is a

Official Website

Find more companies like Maxion Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

By using this site, you agree to our Terms of Service.